Medicine Description apidra-solostar 100 iu/ml
apidra solostar 100 iu/ml prefilled pens is a medication that contains insulin glulisine, a rapid-acting insulin analog. Its primary mechanism involves facilitating the uptake of glucose by promoting its transport into various tissues, particularly muscle and adipose tissues. Insulin glulisine mimics natural insulin's actions by binding to insulin receptors, triggering a cascade of events that enhance glucose transporter translocation to the cell membrane, thereby increasing glucose absorption. This action leads to a decrease in blood glucose levels, effectively managing hyperglycemia in patients with diabetes.
Indications and Uses of apidra solostar 100 iu/ml prefilled pens
- Management of type 1 diabetes mellitus
- Control of postprandial blood glucose levels in patients with type 2 diabetes mellitus
Side Effects of apidra solostar 100 iu/ml prefilled pens
- Hypoglycemia (low blood sugar)
- Weight gain
- Injection site reactions (such as redness, swelling, or itching)
- Allergic reactions (rare)
Storage and Handling
Store Apidra Solostar pens in the refrigerator between 2°C and 8°C (36°F and 46°F). Once in use, the pen can be kept at room temperature (below 30°C or 86°F) for up to 28 days. Avoid freezing the product and protect it from light.
Patient Advice and Precautions
Patients should be educated on recognizing signs of hypoglycemia and appropriate corrective actions. It is essential to rotate injection sites to minimize lipodystrophy. Regular monitoring of blood glucose levels is crucial for optimal diabetes management. Always consult healthcare providers before making any changes to the diabetes management plan.